View Author
Jagmohan, S.
( S. Jagmohan)
cancer family breast mutation breast cancer colorectal cancer colorectal patient cohort meijers-heijboer hnpcc phenotype hnpcc-like disease colorectal cancer cases hbcc phenotype criteria age !60 years breast cancer risk carrier genet disease table brca 1 age 60 years non-brca 1/brca rotterdam allele age 50 years prevalence chek 2 hbcc criteria hnpcc-like report vasen pathway checkpoint tumor noncarrier diagnosis wijnen rotterdam family cohorts mlh 1 mutation intra-s phase checkpoint dutch founder mutations meijers-heijboer h index cases non-hbcc breast cancer cases study endometrial cancer msh 6 mutation msh 6 genes index 55 families hbcc breast cancer msh 2 mutation difference breast cancer diagnosis dutch cosegregation brca 2 mutations saccharomyces cerevisiae non-hbcc breast cancer vasen h department vahteristo fodde clinic susceptibility presence genome instability cycle phase carcinoma li-fraumeni syndrome variant erasmus mc disease phenotype coding sequences
1 Most Recent Publications
|
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype
(Article)
Meijers-Heijboer, E.J. Moslein, G. Bos, R.R. van den Snoo, A. de Schutte, A.E.M. Franken, P.F. Fat, G.T. Jagmohan, S. Chapman, P. Brekelmans, C.T. Wijnen, J. Vasen, H. Lynch, H. Ouweland, A.M.W. van den Klijn, J.G.M. Hollestelle, A. Wasielewski, M. Fodde, R. Wagner, A. Elstrodt, F. Verkuijlen, P. Tops, C. Burn, J. |
2003-01-01
|